Balyasny Asset Management LLC Harmony Biosciences Holdings, Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $2.07 Million - $2.53 Million	64,895 Added 34.2%	254,650 $8.34 Million
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $8.54 Million - $10.5 Million	-279,968 Reduced 59.6%	189,755 $6.68 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $14.5 Million - $25.3 Million	469,723 New	469,723 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $3.49 Million - $4.49 Million	-102,292 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $2.63 Million - $3.95 Million	102,292 New	102,292 $3.92 Million

242

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.94B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.